Mirum Pharmaceuticals, Inc. (MIRM)
CIK 1759425 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Mirum Pharmaceuticals, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Nov 4, 2026 | 4 | 0001614740-26-000015 |
| Nov 4, 2026 | 144 | 0001670138-26-000007 |
| Nov 4, 2026 | 144 | 0001950047-26-010687 |
| Nov 3, 2026 | 10-Q | 0001759425-26-000062 |
| Nov 3, 2026 | 8-K | 0001759425-26-000061 |
| Oct 26, 2026 | 8-K | 0001759425-26-000054 |
| Oct 19, 2026 | 4 | 0001974200-26-000014 |
| Oct 14, 2026 | 4 | 0002155916-26-000004 |
| Oct 13, 2026 | 8-K | 0001759425-26-000051 |
| Oct 6, 2026 | 4 | 0001614740-26-000014 |
| Sep 28, 2026 | 8-K | 0001759425-26-000049 |
| Sep 22, 2026 | 3 | 0002155916-26-000003 |
| Sep 15, 2026 | 4 | 0001197350-26-000010 |
| Sep 15, 2026 | 144 | 0001197350-26-000011 |
| Sep 8, 2026 | 8-K | 0001759425-26-000047 |
| Sep 3, 2026 | 4 | 0001974200-26-000013 |
| Sep 3, 2026 | 4 | 0001614740-26-000013 |
| Sep 2, 2026 | 144 | 0001950047-26-008986 |
| Sep 1, 2026 | 144 | 0001950047-26-008900 |
| Aug 19, 2026 | 4 | 0001974200-26-000012 |
| Aug 18, 2026 | 144 | 0001950047-26-008352 |
| Aug 13, 2026 | SCHEDULE 13G/A | 0001274173-26-000210 |
| Aug 12, 2026 | 4 | 0001197350-26-000009 |
| Aug 11, 2026 | 4 | 0001614740-26-000012 |
| Aug 11, 2026 | 144 | 0001950047-26-007935 |